Clinical Trial Update: Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery [NA]

View source ↗

Summary

Clinical trial comparing rivaroxaban to enoxaparin for preventing venous thromboembolism after bariatric surgery in morbid obesity patients; currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Alexandria University | Conditions: Morbid Obesity, Bariatric Surgery Candidate | NA | Status: RECRUITING